Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Diffusion Pharmaceuticals completes enrollment in phase II trans-sodium crocetinate trial

March 18, 2013

Targeting DNA repair with ATX-101 for enhancing sensitivity to anticancer drugs

March 18, 2013

Oncodesign's IMODI project wins award from French government

March 18, 2013

Ligand signs global license agreement with Spectrum for Captisol-enabled melphalan

March 15, 2013

Isofol Medical completes first part of preclinical safety program for Modufolin

March 15, 2013

G-202 obtains FDA orphan drug designation

March 15, 2013

Oxford Gene Technology obtains license to prostate cancer biomarker

March 15, 2013

Pfizer prepares new BRD4 inhibitors

March 15, 2013

Researchers at Roche prepare new protein kinase inhibitors for cancer

March 14, 2013

Promising antitumor activity seen for NOV-C-ter in vitro and in vivo

March 14, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...